Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypes.

Boi, Michela; Todaro, Maria; Vurchio, Valentina; Yang, Shao Ning; Moon, John; Kwee, Ivo; Rinaldi, Andrea; Pan, Heng; Crescenzo, Ramona; Cheng, Mangeng; Cerchietti, Leandro; Elemento, Olivier; Riveiro, Maria E; Cvitkovic, Esteban; Bertoni, Francesco; Inghirami, Giorgio.
Oncotarget; 7(48): 79637-79653, 2016 Nov 29.
Artigo em Inglês | MEDLINE | ID: mdl-27793034